SynthesisClinical and experimental medicine2023

Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis.

Jin-Cheng Tian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.